Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Cyclopharm - Managing Director's Address to Shareholders (ASX:CYC)

Good morning ladies and gentlemen, my name is James McBrayer, the Managing Director of Cyclopharm. Slide 7 – Financial Highlights To begin, I would like to provide a review of our financ...read more

Cyclopharm - 2021 AGM Presentation (ASX:CYC)

To view the presentation, download the attached PDF.

Cyclopharm - Chairman's Address to Shareholders (ASX:CYC)

Good morning ladies and gentlemen, and fellow shareholders. Thank you for joining us for today’s virtual Annual General Meeting of Cyclopharm Limited. My name Is David Heaney, Chairman of t...read more

Chimeric Therapeutics - Appendix 4C - quarterly (ASX:CHM)

Chimeric Therapeutics Limited (“the Company”) (ASX: CHM), a clinical stage cell therapy company, is pleased to provide a summary of its activities for the quarter ended 31 March 2021. ...read more

Chimeric Therapeutics - Successful Completion of First Patient Cohort Phase 1 Trial (ASX:CHM)

Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), a clinical stage cell therapy company, is pleased to provide an update to its recent announcement and confirm th...read more

Chimeric Therapeutics - Successful Completion of Dosing in First Patient Cohort (ASX:CHM)

Chimeric Therapeutics, a clinical stage cell therapy company, is pleased to announce the successful completion of the planned dosing of the first patient cohort (n=4) in the phase 1 dose escalation ...read more

Cyclopharm - Confirmation of Technegas USFDA Timetable (ASX:CYC)

Cyclopharm Limited’s (ASX: CYC) provides the following update of the US Food & Drug Administration’s (USFDA) timetable in respect of approval of the Company’s New Drug Applicat...read more

Chimeric Therapeutics - Half Yearly Report and Accounts (ASX:CHM)

To view the report, download the attached PDF.

Cyclopharm Results Summary (ASX:CYC)

Cyclopharm Limited (ASX: CYC) is pleased to provide the following update on its business and financial performance for FY2020, including progress towards gaining United States Food and Drug Administ...read more

Cyclopharm - Preliminary Final Report (ASX:CYC)

To view the report, download the attached PDF.

Cyclopharm - Dividend/Distribution (ASX:CYC)

To view the Notification of dividend / distribution, download the attached PDF.

Cyclopharm Receives $3.1M R&D Tax Incentive for FY2020 (ASX:CYC)

AusIndustry has approved Cyclopharm Limited’s (ASX: CYC) inclusion of certain expensed costs associated with its overseas research and domestic development activities as part of its applicatio...read more

Cyclopharm - Proposed issue of Securities (ASX:CYC)

To view the Proposed issue of securities, download the attached PDF.

Cyclopharm Capital Raising Presentation (ASX:CYC)

To view the presentation, download the attached PDF.

Cyclopharm Successfully Completes A$30 Million Placement (ASX:CYC)

Cyclopharm Limited (“CYC” or the “Company”) is pleased to announce it has successfully completed a share placement (“Placement”) to institutional and sophisticate...read more

Viewing: 91 - 105 of 154 Previous | Next